22nd Century Group Inc's Stock Drops 12.26%, but Shows Recent Recovery

Business by 2FIRSTS.ai
Dec.06.2023
22nd Century Group Inc's Stock Drops 12.26%, but Shows Recent Recovery
22nd Century Group Inc's stock price fell 12.26% from its previous closing price of 0.26, despite a 10.19% increase in the past five trading days.

According to a report by Zacks Investment Research, the stock price of 22nd Century Group Inc (NASDAQ: XXII) has dropped by 12.26 percentage points, closing at 0.26 below its previous closing price.

 

Despite this, the company's stock price has risen by 10.19% over the past five trading days. The VLN tobacco products of 22nd Century Group have been certified by the US FDA as reduced-risk tobacco products for the first time.

 

The question of whether the stock of 22nd Century Group Inc. (NASDAQ: XXII) is worth investing in has received mixed market reactions. The company's stock has experienced a 10.19% increase over the past week, but has seen declines of 50.64% and 84.90% over the past 30 days and 90 days respectively.

 

The performance of 22nd Century Group Inc. (NASDAQ: XXII) in recent times has been unable to surpass its 52-week low, resulting in the company sustaining a loss of -98.77% over a period of time. However, in the past five trading days, the stock has shown some recovery, reaching a gain of +10.19%. Nonetheless, it has still dropped by 98.43% compared to the 200-day moving average of 0.3131 USD.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
The EU’s consultation on the Cardiovascular Health Plan, though not mentioning nicotine, has sparked debate over novel tobacco regulation. Advocates urge evidence-based recognition of harm reduction products, while opponents call for tighter rules. The plan may influence TPD III, drawing close scrutiny from both industry and health groups.
Sep.01
2Firsts Analysis: 69.8% of North American Cannabis Vapes Lack Clear Ingredient Labeling, Raising Compliance and Safety Concerns
2Firsts Analysis: 69.8% of North American Cannabis Vapes Lack Clear Ingredient Labeling, Raising Compliance and Safety Concerns
In August 2025, the Journal of Studies on Alcohol and Drugs published a study analyzing the packaging of Delta-8 THC products in North America. 2Firsts focused on the cannabis vape segment, which accounts for 37.9% of the sample, often with high concentrations—yet 69.8% lacked clear potency information, and only 11.7% carried health warnings on the main display panel.
Aug.15 by 2FIRSTS.ai
South African School Raid Uncovers 221 e-cigarettes, Marijuana, and Knives
South African School Raid Uncovers 221 e-cigarettes, Marijuana, and Knives
221 e-cigarettes, 7 bags of marijuana, and 10 knives were seized in a raid at a South African school.
Sep.12 by 2FIRSTS.ai
Relx Technology Q2 2025 Financial Report: Net Revenue Grew by 40.3% Year-over-year to 880 Million Yuan, Net Profit Increased by 35.6%
Relx Technology Q2 2025 Financial Report: Net Revenue Grew by 40.3% Year-over-year to 880 Million Yuan, Net Profit Increased by 35.6%
In the second quarter of 2025, Relx Technology achieved a net revenue of 880 million yuan, representing a year-over-year increase of 40.3% and a quarter-over-quarter increase of 8.9%. The net profit reached 290 million yuan, up by 35.6% year-over-year. The gross profit was 240 million yuan, with a gross margin of 27.5%.
Aug.22 by 2FIRSTS.ai
Denver Flavored-Tobacco Ban Spurs Ballot Fight; Former NYC Mayor Donates $1.5 Million to Back Sales Ban
Denver Flavored-Tobacco Ban Spurs Ballot Fight; Former NYC Mayor Donates $1.5 Million to Back Sales Ban
Michael R. Bloomberg donated $1.5M to back Denver’s flavored-tobacco ban ahead of a Nov. 4 referendum, which vape retailers oppose.
Oct.09 by 2FIRSTS.ai
FDA Urges Nicotine Pouch Manufacturers to Use Child-Resistant Packaging as Exposure Cases Increase
FDA Urges Nicotine Pouch Manufacturers to Use Child-Resistant Packaging as Exposure Cases Increase
The US FDA asks nicotine pouch makers to use child-resistant packaging. From April 2022 to March 2025, US poison centers reported more cases of children under 5 being exposed to nicotine pouches. These pouches are very dangerous for kids. The FDA has approved 20 products with this packaging and shared safety tips.
Sep.03 by 2FIRSTS.ai